Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Australia
  4. Australian Stock Exchange
  5. Integral Diagnostics Limited
  6. News
  7. Summary
    IDX   AU000000IDX2

INTEGRAL DIAGNOSTICS LIMITED

(IDX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Integral Diagnostics : Acquires Radiology Business for $27 Million

09/30/2021 | 05:37am EST


ę MT Newswires 2021
All news about INTEGRAL DIAGNOSTICS LIMITED
2021Integral Diagnostics Names New CFO
MT
2021Integral Diagnostics Announces Appointment of Craig White as Chief Financial Officer Ef..
CI
2021Integral Diagnostics Limited Announces Resignation of Rupert Harrington as Non-Executiv..
CI
2021Notification regarding unquoted securities - IDX
PU
2021Integral Diagnostics Limited completed the acquisition of The X-Ray Group.
CI
2021INTEGRAL DIAGNOSTICS : Acquires Radiology Business for $27 Million
MT
2021Integral Diagnostics Limited agreed to acquire The X-Ray Group for AUD 45.9 million.
CI
2021INTEGRAL DIAGNOSTICS' : After-Tax Net Profit Jumps 36% in FY21
MT
2021Integral Diagnostics Seeks Acquisitions
CI
2021Integral Diagnostics Limited Declares Fully Franked Final Dividend for the Year Ended J..
CI
More news
Financials
Sales 2022 381 M 274 M 274 M
Net income 2022 34,3 M 24,7 M 24,7 M
Net Debt 2022 189 M 135 M 135 M
P/E ratio 2022 25,1x
Yield 2022 2,84%
Capitalization 862 M 621 M 619 M
EV / Sales 2022 2,76x
EV / Sales 2023 2,47x
Nbr of Employees 1 524
Free-Float 88,3%
Chart INTEGRAL DIAGNOSTICS LIMITED
Duration : Period :
Integral Diagnostics Limited Technical Analysis Chart | IDX | AU000000IDX2 | MarketScreener
Technical analysis trends INTEGRAL DIAGNOSTICS LIMITED
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 13
Last Close Price 4,25 AUD
Average target price 5,23 AUD
Spread / Average Target 23,0%
EPS Revisions
Managers and Directors
Ian Kadish CEO, Executive Director & Managing Director
Anne Lockwood Chief Financial & Commercial Officer
Helen Kurincic Independent Non-Executive Chairman
John Atkin Independent Non-Executive Director
Raelene Murphy Independent Non-Executive Director
Sector and Competitors